Related Experiment Video

Updated: Aug 22, 2026

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess
03:42

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess

Published on: March 15, 2024

L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage

P C Top1, W J E Tissing, J W Kuiper

  • 1Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.

Pediatric Blood & Cancer
|September 16, 2004
PubMed

Insights

L-asparaginase therapy for pediatric leukemia can cause pancreatitis. A successful treatment involved percutaneous drainage for severe necrotizing pancreatitis in a child.

Area of Science:

  • Oncology
  • Pediatric Hematology
  • Gastroenterology

Background:

  • L-asparaginase is crucial for treating childhood acute lymphoblastic leukemia (ALL).
  • Pancreatitis is a known complication of L-asparaginase treatment, occurring in 2-16% of pediatric cancer patients.
  • While often self-limiting, L-asparaginase-induced pancreatitis can rarely lead to severe necrotizing or hemorrhagic forms.

Observation:

  • A pediatric patient with leukemia developed severe necrotizing pancreatitis attributed to L-asparaginase toxicity.
  • The patient's condition was complicated by infection within the necrotic pancreatic tissue.

Findings:

  • The severe necrotizing pancreatitis was successfully managed using percutaneous drainage.
  • This intervention facilitated the flushing of infected necrotic pancreatic segments, leading to recovery.

Implications:

  • Percutaneous drainage offers a viable treatment option for severe, infected necrotizing pancreatitis induced by L-asparaginase in pediatric leukemia patients.
  • This approach may prevent the need for more invasive surgical interventions.
  • Highlights the importance of vigilant monitoring for pancreatitis during L-asparaginase therapy and prompt management of severe cases.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...